Starting in 2025, the Eylea franchise as a whole began to decline due to competitive pressure from long-acting Vabysmo, which competes with Eylea HD, and Pabvlu, a biosimilar version of the original ...

From White House celebrations to the Washington Examiner's report card, here is the latest coverage on the second Trump ...

Are voters having second thoughts about President Donald Trump as he reaches the 100-day mark into his second term? Here’s what a new poll found.

As President Donald Trump reached the 100th day of his second term April 29, polls showed decreases in his approval ratings ...

In the final Reuters/Ipsos poll of April, Trump's approval rating holds at 42% amid concerns over the economy and immigration ...

Senate Democratic Leader Chuck Schumer (D-N.Y.) dismissed a question about his 17-percent approval rating when asked by CNN’s ...

CNN's Harry Enten completely trashed the premise that the only reason President Donald Trump's 100-day approval rating is ...

President Trump’s approval rating is lower than any modern president after 100 days in office, with voters disapproving of ...

According to CNN’s polling data, Democrats say they’re not satisfied with their party’s leadership. CNN’s Kaitlan Collins ...

BridgeBio's valuation relies on the commercialization of Attruby, but the drug's full potential may be undermined by tafamidis’ patent extension, introduction of generic alternatives, and other ...

Newsweek's tracker shows that Trump's approval rating currently sits at 44 percent, while 52 percent disapprove.

To celebrate his 100th day in office, Donald Trump held a rally in Michigan—where he, his team, and his fans celebrated the ...